Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.75
Bid: 11.00
Ask: 12.50
Change: -0.50 (-4.08%)
Spread: 1.50 (13.636%)
Open: 12.25
High: 0.00
Low: 0.00
Prev. Close: 12.25
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Oct 2016 07:00

RNS Number : 5138M
Carclo plc
14 October 2016
 

14 October 2016

Carclo plc

("Carclo", the "Company" or the "Group")

 

Trading Update

 

The Board is pleased to announce that the Group has continued to trade well in the current financial year and its trading performance remains in line with the Board's expectations for the year ending 31 March 2017. The Group will announce its results for the half year ended 30 September 2016 on 15 November 2016.

 

Technical Plastics delivered a good first half performance with customer demand in line with the Board's expectations and growing net margins; the Board expects this division to have a stronger second half trading performance. In LED Technologies, our Wipac luxury and supercar lighting business has performed well, demonstrating good product demand and with all of its current design, development and tooling projects on plan; this division is expected to report another strong performance in the second half of the financial year. The Aerospace division has benefited from stable demand in the first half of the financial year and is expected to trade in line with the Board's expectations for the full year.

 

Approximately two thirds of Group revenue is currently derived from outside the UK and, therefore, movements in foreign exchange rates have an impact on our financial results. The Group had foreign exchange contracts in place prior to the EU Referendum and this has limited the net benefit from foreign exchange rates in the first half of the financial year. Assuming that sterling does not strengthen significantly, we do expect some further net benefit from the retranslation of overseas profits during the second half of the financial year.

 

Group debt was slightly higher as at 30 September 2016 than at 31 March 2016 primarily due to the impact of currency movements on the re-translation of the Group's US dollar and Euro denominated medium term loans. Group debt is expected to reduce by 31 March 2017.

 

As outlined in our trading statement of 31 August 2016, the Group's IAS 19 pension deficit is expected to have increased significantly due to the material decrease in the corporate bond yield used to discount the pension liability. However, the cash cost of the pension deficit has remained at similar levels with the Group paying in the current year an annual recovery plan payment of £1.2 million and pension scheme administration costs of £0.7 million. As expected, due to the materially increased IAS19 pension deficit extinguishing the Company's distributable reserves, the Group did not pay the recommended final dividend of 1.95 pence per share which was referred to in the results announcement made on 7 June 2016.

 

The Board continues to look forward to a year of strong trading and good growth in both of its main divisions.

 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne

 

 

 

Notes to editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the Group has been investing in lower cost regions and new technologies.

 

Approximately three fifths of Group revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFIIIDLVLIR
Date   Source Headline
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.